CN Stock MarketDetailed Quotes
301277 Newland Pharmaceutical
- 15.67
- -0.15-0.95%
Market Closed Nov 8 15:00 CST
4.39BMarket Cap26.74P/E (TTM)
16.21High15.59Low72.16KlotVolume16.13Open15.82Pre Close114.07MTurnover10.00%Turnover Ratio27.59P/E (Static)280.06MShares18.3852wk High2.91P/B1.13BFloat Cap9.0152wk Low18.98Limit Up72.16MShs Float24.24Historical High12.66Limit Down3.92%Amplitude9.01Historical Low0.29Dividend TTM15.81Avg Price40.89KlotAsk1.83%Div YieldTTM100Lot Size30.19KlotBid
Newland Pharmaceutical Key Stats
EPS
According to the latest financial report of Newland Pharmaceutical, the latest earnings per share (TTM) for the company is 0.51. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Newland Pharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 5.39.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Newland Pharmaceutical shows that the company's current ratio is 6.39, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Newland Pharmaceutical, the quick ratio is 6.18, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Newland Pharmaceutical? The latest ROE figure is 9.59%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Newland Pharmaceutical, the total asset return on investment (ROA) is 8.47%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Newland Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 41.01%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Newland Pharmaceutical, the net profit margin is 26.41%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data